4//SEC Filing
Pavliv Leo 4
Accession 0001209191-21-039925
CIK 0001087294other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:11 PM ET
Size
8.8 KB
Accession
0001209191-21-039925
Insider Transaction Report
Form 4
Pavliv Leo
Vice President, Operations
Transactions
- Award
Options (right to buy)
2021-03-17+5,000→ 5,000 totalExercise: $3.22From: 2025-03-17Exp: 2031-03-17→ Common Stock (5,000 underlying) - Tax Payment
Common Stock
2021-03-17$3.22/sh−2,870$9,241→ 168,118 total
Footnotes (2)
- [F1]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
- [F2]100% vesting on March 17, 2025.
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001408593
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:11 PM ET
- Size
- 8.8 KB